Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) had its price target raised by equities researchers at Citigroup from $32.00 to $33.00 in a report issued on Tuesday, Stock Target Advisor reports. The firm presently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 145.17% from the stock’s current price. Amylyx […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) was upgraded by analysts at Citigroup to a “buy” rating in a note issued to investors on Monday, Stock Target Advisor reports. The firm presently has a $32.00 target price on the stock. Citigroup’s price target suggests a potential upside of 160.80% from the stock’s previous close. NASDAQ:AMLX traded […]
Equities researchers at Citigroup started coverage on shares of Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Rating) in a research report issued on Wednesday, Stock Target Advisor reports. The brokerage set a “buy” rating and a $21.00 price target on the stock. Citigroup’s target price would indicate a potential upside of 148.52% from the company’s previous close. […]